Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Adamas Pharmaceuticals, Inc. News

5 Top Stock Gainers for Monday: Aspen, SoFi, Flexion Therapeutics

Aspen Technology, Sofi Technologies, Flexion Therapeutics, Adamas Pharmaceuticals and Ocular Therapeutix are five top stock gainers for Monday.

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.

Adamas Skyrockets on FDA Approval for Dyskinesia Treatment - Biotech Movers

The Emeryville, Calif.-based firm secures FDA approval for Gocovri as a treatment for dyskinesia in Parkinson's disease patients.

Hurricane Harvey, Now a Category 2, Heads for Oil-Rich Gulf Coast

Hurricane Harvey was upgraded to a category 2 storm overnight and could be a category 3 before the day is over.

Biotech's are quite active Tuesday. Find Out who's moving and why:

Biogen's new spine disease drug outperformed expectations during its commercial debut.

Breaking News

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Roe v. Wade: Google Makes a Major Decision to Protect Privacy

Google will delete a person's location history for going to an abortion clinic.

Elon Musk Drops The Curtain On His Natures

The billionaire and CEO of Tesla remains an enigma despite its omnipresence on social media.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.